ProCE Banner Activity

Key HIV Studies Influencing My Practice Following IAS 2023

Conference Coverage

Read expert faculty members’ summaries of key HIV studies from IAS 2023, including results from studies of HIV treatment, ART adverse events, HIV prevention, and TB coinfection.

Released: August 07, 2023



Joseph J. Eron Jr.

Joseph J. Eron Jr., MD

Herman and Louise Smith Distinguished Professor of Medicine
Adjunct Professor of Epidemiology
Chief, Division of Infectious Diseases
UNC-Chapel Hill School of Medicine
Chapel Hill, North Carolina

Monica Gandhi

Monica Gandhi, MD, MPH

Professor of Medicine
Division of HIV, Infectious Diseases, and Global Medicine
Director, Center for AIDS Research (CFAR)
Medical Director, Ward 86 HIV Clinic
University of California, San Francisco (UCSF)
San Francisco, California

Chloe Orkin

Chloe Orkin, MBChB, FRCP, MD

Professor of Infection and Inequities
Faculty of Medicine and Dentistry
Queen Mary University of London
Blizard Institute
Barts Health NHS Trust
London, United Kingdom

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner


Supported by educational grants from Gilead Sciences, Inc., Janssen Therapeutics, Division of Janssen Products, LP, and ViiV Healthcare.

Gilead Sciences, Inc.

Janssen Therapeutics, Division of Janssen Products, LP

ViiV Healthcare


IAS 2023

ProCE Banner